Javal Vishnukumar Patel
About Javal Vishnukumar Patel
Data last updated:
Javal Vishnukumar Patel is a Director at Shankus Acme Pharma Private Limited (since 2016), Designated Partner at Acmedix Pharma Llp (since 2018) and Director at Acmedix Pharma Private Limited (since 2026), and holds 3 more current directorships. The companies operate in Pharma, Real Estate and Construction and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹19.27 Cr; the largest is Shankus Acme Pharma Private Limited at ₹13.15 Cr (FY 2025). Earlier, Javal Vishnukumar Patel was a Designated Partner at Acme Pharmacy Llp (2021–2025) and Director at German Remedies Pharmaceuticals Private Limited (2013–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shankus Acme Pharma Private Limited U24230GJ2012PTC069152 | Director | 29 Nov 2016 | 2012 | ₹13.15 Cr (FY 2025) | Active |
| Acmedix Pharma Llp AAM-5488 | Designated Partner | 03 May 2018 | 2018 | ₹6.12 Cr (FY 2023) | Active |
| Acmedix Pharma Private Limited U21001GJ2026PTC173760 | Director | 18 Feb 2026 | 2026 | Active | |
| Finfirst Woodsmen Llp ACB-9041 | Partner | 02 Nov 2023 | 2023 | Active | |
| Finfirstds Consultants Llp ACB-3011 | Partner | 10 Aug 2023 | 2023 | Active | |
| Emca Life Care Llp AAH-7162 | Designated Partner | 28 Oct 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Acme Pharmacy Llp AAY-6489 | Designated Partner | 17 Sep 2021 | 2021 | Active | |
| German Remedies Pharmaceuticals Private Limited U24230GJ2010PTC063425 | Director | 09 Dec 2013 | 2010 | ₹547 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Javal Vishnukumar Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dashrathbhai Kalidas Patel | 00155539 | Shankus Acme Pharma Private Limited , Acmedix Pharma Llp and 1 more | Director |
| Dilip Shankarbhai Chaudhary | 01354482 | Shankus Acme Pharma Private Limited , Acmedix Pharma Llp and 1 more | Director |
| Neerav Dad | 05276181 | Finfirst Woodsmen Llp , Finfirstds Consultants Llp | Designated Partner |
| Pallavi Daga | 10173176 | Finfirst Woodsmen Llp , Finfirstds Consultants Llp | Designated Partner |
| Arbind Kumar Shah | 02845514 | Emca Life Care Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Javal Vishnukumar Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Javal Vishnukumar Patel
Javal Vishnukumar Patel currently holds 6 directorships: Shankus Acme Pharma Private Limited (Director, since 29 Nov 2016, revenue ₹13.15 Cr (FY 2025)); Acmedix Pharma Llp (Designated Partner, since 03 May 2018, revenue ₹6.12 Cr (FY 2023)); Acmedix Pharma Private Limited (Director, since 18 Feb 2026); Finfirst Woodsmen Llp (Partner, since 02 Nov 2023); Finfirstds Consultants Llp (Partner, since 10 Aug 2023); and 1 more.
Javal Vishnukumar Patel was first appointed on 09 Dec 2013 as Director at German Remedies Pharmaceuticals Private Limited. The most recent appointment on record is 18 Feb 2026 at Acmedix Pharma Private Limited.
The 2 current companies of Javal Vishnukumar Patel that report revenue have a combined latest revenue of ₹19.27 Cr: Shankus Acme Pharma Private Limited ₹13.15 Cr (FY 2025); Acmedix Pharma Llp ₹6.12 Cr (FY 2023).
Javal Vishnukumar Patel held 2 earlier board appointments: Acme Pharmacy Llp (Designated Partner, 17 Sep 2021 to 30 Apr 2025); German Remedies Pharmaceuticals Private Limited (Director, 09 Dec 2013 to 29 Mar 2018).
The current boards of Javal Vishnukumar Patel's companies include Dashrathbhai Kalidas Patel (Shankus Acme Pharma Private Limited), Dilip Shankarbhai Chaudhary (Shankus Acme Pharma Private Limited), Neerav Dad (Finfirst Woodsmen Llp), Pallavi Daga (Finfirst Woodsmen Llp), Arbind Kumar Shah (Emca Life Care Llp).